Because researchers observed a positive correlation between MAPK pathway activity and PD-L1 expression in human cancer cells32–34, we asked whether activation of EphA4/ERK signaling by RNase1 affects PD-L1 protein levels in HCCs. Here, RNASE1 is linked to cancer.